We are live on ! Find out more
ORGS icon

Orgenesis Inc. Common Stock
ORGS

Delisted

ORGS was delisted on the 18th of October, 2024.

Back to rankings

10 hedge funds and large institutions have $1.62M invested in Orgenesis Inc. Common Stock in 2018 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

8,684% more capital inflows, than outflows

Capital inflows: $1.58M | Capital outflows: $18K

1.53% more ownership

Funds ownership: 0.19% → 1.72% (+1.5%)

0% more funds holding

Funds holding: 10 → 10 (0)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

Holders
10
Holders Change
–
Holders Change %
0%
% of All Funds
0.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$1.35M
2
BlackRock
BlackRock
New York
+$178K
3
Panagora Asset Management
Panagora Asset Management
Massachusetts
+$56.3K

Top Sellers

Rank Fund Capital Flow
1
Bank of America
Bank of America
North Carolina
-$7.99K
2
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$5K
3
UBS Group
UBS Group
Switzerland
-$3.99K
4
SWS Partners
SWS Partners
Ohio
-$1K

ORGS Hedge Fund Activity: Q2 2018 in Review

10 of the 4,386 institutional investors tracked by Wall St. Rank reported a position in Orgenesis Inc. Common Stock (ORGS) for Q2 2018, worth a combined $1.62M — up 711% from $200K a quarter earlier.

Fund positioning in ORGS was balanced in Q2 2018: 2 funds opened new positions, 2 closed out, 1 added to existing stakes and 2 trimmed.

The largest buyer was Vanguard Group, opening a new position worth an estimated $1.35M. The largest seller was Bank of America, cutting an estimated $7.99K.

  • 10 institutional investors held Orgenesis Inc. Common Stock (ORGS) as of Q2 2018, unchanged from Q1 2018.
  • Funds reported $1.62M of Orgenesis Inc. Common Stock stock for Q2 2018, up 711% quarter-over-quarter.
  • 2 funds opened new Orgenesis Inc. Common Stock positions in Q2 2018 and 2 closed out, a net change of 0 holders.
  • The largest Orgenesis Inc. Common Stock buyer in Q2 2018 was Vanguard Group, an estimated $1.35M added.
  • The largest Orgenesis Inc. Common Stock seller in Q2 2018 was Bank of America, an estimated $7.99K sold.

Based on aggregated 13F filings for Q2 2018.